Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

8,425 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The use of 13C-erythromycin as an in vivo probe to evaluate CYP3A-mediated drug interactions in rats.
Sugiyama E, Kikuchi A, Inada M, Sato H. Sugiyama E, et al. Among authors: sato h. J Pharm Sci. 2011 Sep;100(9):3995-4005. doi: 10.1002/jps.22616. Epub 2011 May 26. J Pharm Sci. 2011. PMID: 21618542
Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs.
Shitara Y, Sato H, Sugiyama Y. Shitara Y, et al. Among authors: sato h. Annu Rev Pharmacol Toxicol. 2005;45:689-723. doi: 10.1146/annurev.pharmtox.44.101802.121444. Annu Rev Pharmacol Toxicol. 2005. PMID: 15822193 Review.
Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil.
Shitara Y, Hirano M, Sato H, Sugiyama Y. Shitara Y, et al. Among authors: sato h. J Pharmacol Exp Ther. 2004 Oct;311(1):228-36. doi: 10.1124/jpet.104.068536. Epub 2004 Jun 11. J Pharmacol Exp Ther. 2004. PMID: 15194707
Role of CXC chemokines in the enhancement of LPS-induced neutrophil accumulation in the lung of mice by dexamethasone.
Aoki K, Ishida Y, Kikuta N, Kawai H, Kuroiwa M, Sato H. Aoki K, et al. Among authors: sato h. Biochem Biophys Res Commun. 2002 Jun 28;294(5):1101-8. doi: 10.1016/S0006-291X(02)00573-9. Biochem Biophys Res Commun. 2002. PMID: 12074590
Estimating pediatric doses of drugs metabolized by cytochrome P450 (CYP) isozymes, based on physiological liver development and serum protein levels.
Suzuki S, Murayama Y, Sugiyama E, Hirunpanich V, Saito K, Sekiyama M, Sato H. Suzuki S, et al. Among authors: sato h. Yakugaku Zasshi. 2010 Apr;130(4):613-20. doi: 10.1248/yakushi.130.613. Yakugaku Zasshi. 2010. PMID: 20372009
Ethyl docosahexaenoate decreased Neoral absorption due to particle size enlargement.
Hirunpanich V, Sugiyama E, Sato H. Hirunpanich V, et al. Among authors: sato h. Int J Pharm. 2008 Sep 1;361(1-2):251-2. doi: 10.1016/j.ijpharm.2008.05.036. Epub 2008 Jun 5. Int J Pharm. 2008. PMID: 18577438
Improvement of cyclosporine A bioavailability by incorporating ethyl docosahexaenoate in the microemulsion as an oil excipient.
Hirunpanich V, Sato H. Hirunpanich V, et al. Among authors: sato h. Eur J Pharm Biopharm. 2009 Oct;73(2):247-52. doi: 10.1016/j.ejpb.2009.06.011. Epub 2009 Jun 26. Eur J Pharm Biopharm. 2009. PMID: 19560537
Developing in vitro-in vivo correlation of risperidone immediate release tablet.
Saibi Y, Sato H, Tachiki H. Saibi Y, et al. Among authors: sato h. AAPS PharmSciTech. 2012 Sep;13(3):890-5. doi: 10.1208/s12249-012-9814-3. Epub 2012 Jun 14. AAPS PharmSciTech. 2012. PMID: 22696224 Free PMC article.
Simultaneous optimization of limited sampling points for pharmacokinetic analysis of amrubicin and amrubicinol in cancer patients.
Makino Y, Watanabe M, Makihara RA, Nokihara H, Yamamoto N, Ohe Y, Sugiyama E, Sato H, Hayashi Y. Makino Y, et al. Among authors: sato h. Asia Pac J Clin Oncol. 2016 Sep;12(3):259-64. doi: 10.1111/ajco.12485. Epub 2016 Mar 7. Asia Pac J Clin Oncol. 2016. PMID: 26948073
In vitro and in vivo correlation of the inhibitory effect of cyclosporin A on the transporter-mediated hepatic uptake of cerivastatin in rats.
Shitara Y, Hirano M, Adachi Y, Itoh T, Sato H, Sugiyama Y. Shitara Y, et al. Among authors: sato h. Drug Metab Dispos. 2004 Dec;32(12):1468-75. doi: 10.1124/dmd.32.12.. Drug Metab Dispos. 2004. PMID: 15550721
8,425 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page